00570 中國中藥
按盘价 
2.170 -0.090 (-3.982%) 盈利能力分析
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| 资产回报率 (%) | 3.535% | 2.123% | 5.564% | 5.074% | 5.061% |
| 股东资金回报率 (%) | 6.219% | 3.833% | 10.231% | 9.590% | 9.872% |
| 资本运用回报率 (%) | 4.634% | 2.994% | 6.997% | 6.509% | 7.447% |
边际利润分析
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| 毛利率 (%) | 51.178% | 50.324% | 62.086% | 61.637% | 59.883% |
| 未计利息、税项、折旧及摊销前利润率 (%) | 13.770% | 14.656% | 18.580% | 21.120% | 18.014% |
| 税前边际利润率 (%) | 6.757% | 5.873% | 13.228% | 15.062% | 15.045% |
| 纯利率 (%) | 7.092% | 5.344% | 10.145% | 11.234% | 11.089% |
变现能力分析
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| 流动比率 (X) | 2.122 X | 1.778 X | 2.077 X | 2.008 X | 1.375 X |
| 速动比率 (X) | 1.483 X | 1.181 X | 1.502 X | 1.357 X | 0.954 X |
财务杠杆分析
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| 总负债 / 总资产比率 (%) | 35.426% | 35.606% | 37.726% | 36.847% | 41.335% |
| 总债项 / 总资产比率 (%) | 13.921% | 14.150% | 13.915% | 15.778% | 17.806% |
| 净债项 / 总资产比率 (%) | 5.781% | 5.549% | 5.960% | 5.381% | 0.519% |
| 总债项 / 股东资金比率 (%) | 24.386% | 25.003% | 25.679% | 28.901% | 34.783% |
| 长期债项 / 股东资金比率 (%) | 10.353% | 2.623% | 14.671% | 14.072% | 1.577% |
| 净债项 / 股东资金比率 (%) | 10.127% | 9.805% | 10.999% | 9.856% | 1.014% |
| 净现金 / (债项) ($) | (21.43亿) | (19.78亿) | (21.69亿) | (17.80亿) | (1.69亿) |
| 每股净现金 / (债项) ($) | (0.426) | (0.393) | (0.431) | (0.354) | (0.033) |
| 总债项 / 资本运用比率 (%) | 18.605% | 19.748% | 18.330% | 20.430% | 27.112% |
| 利息盈利率 (X) | 7.152 X | 4.807 X | 12.351 X | 10.115 X | 8.157 X |
营运效率分析
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| 存货周转率日数 (日) | 247.511日 | 284.642日 | 251.414日 | 308.453日 | 291.435日 |
| 应收贸易帐周转率日数 (日) | 169.097日 | 203.656日 | 123.521日 | 92.435日 | 76.917日 |
| 应付贸易帐周转率日数 (日) | 46.644日 | 50.804日 | 38.862日 | 54.865日 | 55.769日 |
| 备注： | 实时报价更新时间为22/11/2024 17:59 |
| 港股实时基本市场行情由香港交易所提供; 香港交易所指定免费发放实时基本市场行情的网站。 | |
| 股东应占溢利/(亏损) (千) | RMB 210,979 |
| 增长率 | -63.545% |
| 每股盈利/(亏损) | RMB 0.042 |
| 每股账面资产净值 (¥) | RMB 4.244 |